Kingsgate Consolidated Limited (ASX:KCN) Marks 100th Gold Pour at Chatree Gold Mine
Kingsgate Consolidated Limited (ASX:KCN) reaches its 100th gold pour milestone at Chatree Gold Mine and reports enhanced operational performance in January 2025.
Tag: Investor Relations
Vonex Limited (ASX:VN8) Announces $13.9M Entitlement Offer and CEO Departure
Vonex Limited (ASX:VN8) announces a $13.9M entitlement offer to repay debt and the departure of CEO Ian Porter.
Predictive Discovery Limited (ASX:PDI) Raises A$69M in Strategic Placement
Predictive Discovery Limited (ASX:PDI) raises A$69M in strategic placement to advance its Bankan Gold Project.
VRX Silica Limited (ASX:VRX) Announces Trading Halt
VRX Silica Limited (ASX:VRX) announces a trading halt pending an environmental approval announcement for its Arrowsmith North project.
Rimfire Pacific Mining Ltd (ASX:RIM) Announces New High-Grade Scandium Opportunity
Rimfire Pacific Mining (ASX:RIM) confirms Currajong Prospect as a high-grade scandium opportunity, planning extensive drilling for 2025.
Australian Gold and Copper Ltd (ASX:AGC) Reports New Copper Exploration Results
Australian Gold and Copper Ltd (ASX:AGC) announces new copper exploration results and identifies additional targets in the Achilles region.
Sarytogan Graphite Limited (ASX:SGA) Updates on Baynazar Copper Exploration
Sarytogan Graphite Limited (ASX:SGA) reports significant progress in its Baynazar copper exploration project, highlighting new anomalies and plans for future drilling.
Santana Minerals Ltd (ASX:SMI) Reports Latest Diamond Drilling Results
Santana Minerals (ASX:SMI) reports new diamond drilling results at the RAS deposit, improving mine planning and resource estimates.
Intelligent Monitoring Group Limited (ASX:IMB) Secures $122.5M New Debt Facility with NAB
Intelligent Monitoring Group Limited (ASX:IMB) secures a $122.5M debt facility with NAB, reducing interest expenses by $6.5M annually and enhancing financial capacity for acquisitions.
Rhythm Biosciences Ltd (ASX:RHY) Completes Genetype Integration
Rhythm Biosciences (ASX:RHY) completes Genetype integration, enhancing commercial operations for geneType™ and ColoSTAT® products.